Literature DB >> 11886194

Burkholderia cepacia complex in cystic fibrosis and non-cystic fibrosis patients: identification of a cluster of epidemic lineages.

A Agodi1, M Barchitta, V Gianninò, A Collura, T Pensabene, M L Garlaschi, C Pasquarella, F Luzzaro, F Sinatra, E Mahenthiralingam, S Stefani.   

Abstract

This study was performed in order to compare Burkholderia cepacia complex strains from cystic fibrosis (CF) and non-CF patients at the genomovar, genetic and epidemiological levels. A total of 92 B. cepacia respiratory tract isolates were obtained from patients attending the following CF centres: Catania and Palermo, Sicily; Gualdo Tadino, Central Italy, and Milan, Northern Italy. A total of 23 B. cepacia isolates were obtained from blood, surgical wound, and intravenous catheter sources of patients without CF, hospitalized in Catania and Varese, Northern Italy. Genomovar status identification, clonality and genetic relatedness determination, antibiotic susceptibility pattern determination and electron microscopy were performed. Transmission of infection was shown in both CF and non-CF patients by identifying clonality of responsible strains. In total 13 clones were involved in cross-transmission episodes. No outbreak was described involving both CF and non-CF patients. The present study indicates the existence of a distinct cluster of strains responsible for epidemics in CF and non-CF patients, based on their genetic relatedness, distinct from strains associated with no or negligible transmissibility. This result suggests that transmissibility is not only associated with a specific genomovar in CF patients, but also with a group of genetically related lineages in CF and non-CF patients. A key role is shown for both segregation measures and careful surveillance of infection, based on selective culture, molecular identification and epidemiological characterization of individual isolates. Copyright 2002 The Hospital Infection Society.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886194     DOI: 10.1053/jhin.2001.1160

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

1.  Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation.

Authors:  A De Soyza; K Morris; A McDowell; C Doherty; L Archer; J Perry; J R W Govan; P A Corris; K Gould
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

2.  Crystal structure of chorismate mutase from Burkholderia thailandensis.

Authors:  Oluwatoyin A Asojo; David M Dranow; Dmitry Serbzhinskiy; Sandhya Subramanian; Bart Staker; Thomas E Edwards; Peter J Myler
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-04-16       Impact factor: 1.056

3.  Antibiotic Consumption and Resistance during a 3-Year Period in Sicily, Southern Italy.

Authors:  Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Maria Clara La Rosa; Claudia La Mastra; Laura Sessa; Pasquale Cananzi; Giuseppe Murolo; Alessandro Oteri; Guido Basile; Antonella Agodi
Journal:  Int J Environ Res Public Health       Date:  2019-06-26       Impact factor: 3.390

4.  Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans.

Authors:  Adrian Wallner; Eoghan King; Eddy L M Ngonkeu; Lionel Moulin; Gilles Béna
Journal:  BMC Genomics       Date:  2019-11-04       Impact factor: 3.969

5.  Concomitant cryptococcosis and burkholderia infection in an asymptomatic lung transplant patient with cystic fibrosis.

Authors:  S Shafaghi; M Pour Abdollah; P Tabarsi; F Ghorbani; S S M Makki; H R Khoddami Vishteh; J Faeghi; K Najafizadeh
Journal:  Int J Organ Transplant Med       Date:  2010
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.